| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,340,000,000 |
| Market
Cap: |
112.96(B) |
| Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
| 52
Week Range: |
$69.43 - $90.4 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 125 |
| Guru Rank Value : 7.5 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,549 |
36,546 |
56,412 |
75,447 |
| Total Sell Value |
$2,684,057 |
$3,094,660 |
$4,783,517 |
$6,318,268 |
| Total People Sold |
2 |
3 |
5 |
5 |
| Total Sell Transactions |
2 |
3 |
8 |
10 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kuntz Richard |
SrVP & Chief Scien, Clin, Reg |
• • – |
2017-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
10,322 |
113,945 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2017-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
11,910 |
59,960 |
|
- |
|
| Hanson Bryan C |
EVP, President, MITG |
• • – |
2017-07-31 |
4 |
A |
$83.97 |
$1,216,725 |
D/D |
14,490 |
151,913 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2017-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
53,591 |
580,698 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2017-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,497 |
71,530 |
|
- |
|
| Hakami Hooman |
EVP & Group President Diabetes |
• • – |
2017-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,528 |
65,473 |
|
- |
|
| Surface Carol A |
SVP, Chief HR Officer |
• • – |
2017-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8,734 |
62,215 |
|
- |
|
| Martha Geoffrey |
EVP & GroupPres Restora Therap |
• • – |
2017-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,925 |
51,831 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2017-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
16,276 |
156,469 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2017-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,131 |
60,426 |
|
- |
|
| Hakami Hooman |
EVP & Group President Diabetes |
• • – |
2017-07-28 |
4 |
D |
$84.29 |
$329,911 |
D/D |
(3,914) |
55,945 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2017-07-28 |
4 |
D |
$84.29 |
$612,788 |
D/D |
(7,270) |
140,193 |
|
- |
|
| Kuntz Richard |
SrVP & Chief Scien, Clin, Reg |
• • – |
2017-07-28 |
4 |
D |
$84.29 |
$389,504 |
D/D |
(4,621) |
103,623 |
|
- |
|
| Martha Geoffrey |
EVP & GroupPres Restora Therap |
• • – |
2017-07-28 |
4 |
D |
$84.29 |
$297,712 |
D/D |
(3,532) |
41,906 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2017-07-28 |
4 |
D |
$84.29 |
$27,816 |
D/D |
(330) |
51,295 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2017-07-28 |
4 |
D |
$84.29 |
$429,373 |
D/D |
(5,094) |
48,050 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2017-07-28 |
4 |
D |
$84.29 |
$2,404,119 |
D/D |
(28,522) |
527,107 |
|
- |
|
| Surface Carol A |
SVP, Chief HR Officer |
• • – |
2017-07-28 |
4 |
D |
$84.29 |
$326,371 |
D/D |
(3,872) |
53,481 |
|
- |
|
| Hanson Bryan C |
EVP, President, MITG |
• • – |
2017-07-17 |
4 |
AS |
$88.57 |
$1,062,840 |
D/D |
(12,000) |
136,912 |
|
- |
|
| Lenehan James T |
Director |
• • – |
2017-07-10 |
4 |
OE |
$52.84 |
$53,368 |
D/D |
1,010 |
46,353 |
|
- |
|
| Anderson Richard H |
Director |
• • – |
2017-06-21 |
4 |
B |
$88.90 |
$497,840 |
D/D |
5,600 |
71,910 |
2.39 |
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2017-06-20 |
4 |
D |
$88.82 |
$625,915 |
D/D |
(7,047) |
57,781 |
|
- |
|
| Pozen Robert C |
Director |
• • – |
2017-06-14 |
4 |
D |
$87.65 |
$55,044 |
D/D |
(628) |
68,987 |
|
- |
|
| Lenehan James T |
Director |
• • – |
2017-05-26 |
4 |
D |
$85.09 |
$55,053 |
D/D |
(647) |
45,343 |
|
- |
|
| Hogan Randall J |
Director |
• • – |
2017-05-02 |
4 |
D |
$84.75 |
$55,088 |
D/D |
(650) |
33,911 |
|
- |
|
700 Records found
|
|
Page 20 of 28 |
|
|
0.78 (0.93%) 
